We are live on ! Find out more
SCM

Scopia Capital Management Portfolio holdings

AUM $146M
1-Year Est. Return 25.93%
This Fund
S&P 500
This Quarter Est. Return
+1.8%
1 Year Est. Return
+25.93%
3 Year Est. Return
+30.87%
5 Year Est. Return
+45.28%
10 Year Est. Return
+379.83%
AUM
$4.85B
AUM Growth
-$566M
Cap. Flow
-$662M
Cap. Flow %
-13.65%
Top 10 Hldgs %
63.37%
Holding
40
New
8
Increased
9
Reduced
10
Closed
5

Sector Composition

Rank Sector Weight
1 Healthcare 24.77%
2 Communication Services 16.55%
3 Real Estate 15.01%
4 Industrials 14.18%
5 Technology 8.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FCE.A
1
DELISTED
Forest City Realty Trust, Inc.
FCE.A
$570M 11.76%
23,585,735
-84,536
-0.4% -$1.95M
SPR
2
DELISTED
Spirit AeroSystems
SPR
$432M 8.92%
7,460,682
+855,390
+13% +$48M
NFLX icon
3
Netflix
NFLX
$307B
$380M 7.84%
25,444,600
-109,780
-0.4% -$1.69M
ITRI icon
4
Itron
ITRI
$4.6B
$309M 6.37%
4,558,387
BIDU icon
5
Baidu
BIDU
$36.3B
$292M 6.02%
1,631,838
-144,369
-8% -$26.2M
JCI icon
6
Johnson Controls International
JCI
$85.3B
$255M 5.27%
5,887,736
-1,668,781
-22% -$69.9M
GWPH
7
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$250M 5.16%
2,494,738
+506,421
+25% +$54.5M
JD icon
8
JD.com
JD
$44B
$244M 5.04%
6,225,674
-4,440,935
-42% -$168M
HZNP
9
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$182M 3.75%
15,308,143
+5,621,881
+58% +$69.9M
SRC
10
DELISTED
SPIRIT REALTY CAPITAL, INC.
SRC
$158M 3.26%
+4,750,226
New +$178M
TMH
11
DELISTED
Team Health Holdings Inc
TMH
$145M 3%
3,338,649
ACOR
12
DELISTED
Acorda Therapeutics
ACOR
$142M 2.94%
60,199
+13,796
+30% +$27.3M
CNMD icon
13
CONMED
CNMD
$1.3B
$141M 2.91%
2,774,045
NDRM
14
DELISTED
NeuroDerm Ltd. Ordinary Shares
NDRM
$131M 2.7%
4,383,358
FNF icon
15
Fidelity National Financial
FNF
$14.6B
$130M 2.68%
4,173,128
-467,002
-10% -$13.5M
OPTU
16
Optimum Communications Inc
OPTU
$301M
$117M 2.42%
+3,629,740
New +$120M
TVTX icon
17
Travere Therapeutics
TVTX
$5.26B
$116M 2.39%
5,973,111
+89,455
+2% +$1.62M
CNDT icon
18
Conduent
CNDT
$259M
$111M 2.29%
6,979,221
+4,018,064
+136% +$65.8M
VST icon
19
Vistra
VST
$48.5B
$106M 2.19%
+6,324,010
New +$99.9M
AR icon
20
Antero Resources
AR
$10.9B
$100M 2.07%
4,643,955
+1,250,872
+37% +$26.8M
CNX icon
21
CNX Resources
CNX
$4.91B
$95M 1.96%
7,631,874
+1,052,974
+16% +$13.6M
UTHR icon
22
United Therapeutics
UTHR
$26.1B
$91.5M 1.89%
705,003
-1,668,184
-70% -$208M
LGND icon
23
Ligand Pharmaceuticals
LGND
$5.82B
$88.4M 1.82%
1,167,886
-697,737
-37% -$48.8M
TRGP icon
24
Targa Resources
TRGP
$57B
$87.3M 1.8%
1,930,592
+462,267
+31% +$23.3M
BIDU icon
25
CALL
Baidu
BIDU
$36.3B
$71.5M 1.48%
+400,000
New +$72.5M

Similar funds

Scopia Capital Management's Q2 2017 Portfolio in Review

As of Q2 2017, Scopia Capital Management held 40 positions worth $4.85B, down 10% from $5.41B the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Scopia Capital Management withdrew a net $662M in Q2 2017, closing 5 positions and reducing 10 holdings. Its most notable exit was Williams Companies, an estimated $141M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 25% a quarter earlier, followed by Communication Services and Real Estate.

Against the trend, Scopia Capital Management opened a new position in SPIRIT REALTY CAPITAL, INC. worth $158M.

  • Scopia Capital Management's largest Q2 2017 buy was SPIRIT REALTY CAPITAL, INC.: 4,750,226 shares worth $158M.
  • Scopia Capital Management added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2017, an estimated $69.9M increase.
  • Scopia Capital Management's biggest Q2 2017 reduction was United Therapeutics, cutting an estimated $208M.
  • Scopia Capital Management fully exited Williams Companies in Q2 2017, selling an estimated $141M.
  • Scopia Capital Management's ten largest holdings make up 63% of its $4.85B portfolio in Q2 2017.
  • Scopia Capital Management opened 8 new positions and closed 5 in Q2 2017.
  • Scopia Capital Management's portfolio value fell 10% quarter-over-quarter to $4.85B.

Based on Scopia Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.